封面
市场调查报告书
商品编码
1098653

鼻腔给药方式的市场规模、占有率、展望、机会 (2022年~2028年):各治疗用途、剂型、容器类型、系统类型、终端用户、流通、地区

Nasal Drug Delivery Mode Market, By Therapeutic Application, By Dosage Form, By Container Type, By System Type, By End Users, By Distribution, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3个工作天内

价格
简介目录

气喘和慢性阻塞性肺病 (COPD) 的盛行率增加,自我投药的采用增加等要素预计推动在预测期间内的全球鼻腔给药方式市场成长。

本报告提供全球鼻腔给药方式的市场调查,市场定义和概要,市场成长的各种影响因素分析,法律制度,市场规模的变化、预测,各种区分、各地区/主要国家的明细,竞争环境,主要企业简介等彙整资讯。

目录

第1章 调查目的、前提条件

第2章 市场展望

第3章 市场动态、法规、趋势分析

  • 市场动态
  • 影响分析
  • 主要的焦点
  • 法规情境
  • 产品的销售/核准
  • PEST分析
  • 波特分析
  • M&A情境

第4章 鼻腔给药方式市场:COVID-19影响

  • COVID-19:流行病学
  • 供给侧面、需求方面的分析
  • 经济影响

第5章 鼻腔给药方式市场:各治疗用途

  • 气喘
  • 鼻炎

第6章 鼻腔给药方式市场:各剂型

  • 粉末
  • 喷雾
  • 凝胶

第7章 鼻腔给药方式市场:各容器类型

  • 加压容器
  • 非加压容器

第8章 鼻腔给药方式市场:各系统类型

  • 多回剂量
  • 二回剂量
  • 单回剂量

第9章 鼻腔给药方式市场:各终端用户

  • 医院
  • 居家医疗

第10章 鼻腔给药方式市场:各流通管道

  • 医院药局
  • 零售药局
  • 线上药局

第11章 鼻腔给药方式市场:各地区

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东、非洲
  • 其他地区

第12章 竞争情形

  • Merck & Co., Inc.
  • GlaxoSmithKline Plc.
  • Astra Zeneca
  • Johnson & Johnson Services Inc.
  • Mystic Pharmaceuticals
  • Bausch Health
  • PendoPharm Inc.
  • Optinose
  • Cadila Pharmaceutical s Ltd.
  • 3M
  • Reddy Laboratories
  • Aptar Group Inc.
  • Neurelis Inc.
  • ENT Technologies Pty Ltd.
  • Becton, Dickinson and Company

第13章 Section

简介目录
Product Code: CMI5047

Drug delivery refers to the technology utilized to present the drug to the desired body site for drug release and absorption. Intranasal drug delivery offers a rapid onset of therapeutic effects (local or systemic). Nasal applications of topical decongestants or anti-inflammatory drugs are most popular topical nasal drug deliveries. Nasal delivery is the logical choice for treatment of diseases in the nose and paranasal sinuses. Over the years, nasal route has gained widespread interest as a promising and an alternative route to oral and parenteral drug delivery.

Market Dynamics:

Growing prevalence of asthma and chronic obstructive pulmonary disease (COPD), increasing adoption of self-administration practices, and increasing preference for nasal drug delivery are some major factors expected to boost the growth of the global nasal drug delivery mode market over the forecast period. Asthma is a major noncommunicable disease (NCD) that affects both children and adults. For instance, according to the Asthma and Allergy Foundation of America (AAFA), more than 25 million people in the U.S. have asthma, about 1 in 13 people. Moreover, over 20 million adults aged 18 and older have asthma in the U.S., and asthma rates are highest in Black adults in the United States.

Key features of the study:

  • This report provides in-depth analysis of the global nasal drug delivery mode market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021 to 2028), considering 2020 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the nasal drug delivery mode market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck & Co., Inc., Astra Zeneca, GlaxoSmithKline Plc, Mystic Pharmaceuticals, PendoPharm Inc., Bausch Health, 3M, Cadila Pharmaceuticals, Optinose, Dr. Reddy Laboratories, Neurelis Inc., Aptar Group, Johnson & Johnson Services Inc., ENT Technologies Pty Ltd., and Becton, Dickinson and Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global nasal drug delivery mode market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery mode market.

Detailed Segmentation:

  • Global Nasal Drug Delivery Mode Market, By Therapeutic Application:
    • Asthma
    • Rhinitis
    • Others
  • Global Nasal Drug Delivery Mode Market, By Dosage Form:
    • Powder
    • Gel
    • Spray
    • Gel
  • Global Nasal Drug Delivery Mode Market, By Container Type:
    • Pressurized Container
    • Non Pressurized
    • Container
  • Global Nasal Drug Delivery Mode Market, By System Type:
    • Multi- Dose
    • Bi-Dose
    • Unit Dose
  • Global Nasal Drug Delivery Mode Market, By End Users:
    • Hospitals
    • Homecare Settings
  • Global Nasal Drug Delivery Mode Market, By Distribution:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Nasal Drug Delivery Mode Market, By Region:
    • North America
    • Latin America
    • Asia Pacific
    • Europe
    • Middle East
    • Africa

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Nasal Drug Delivery Mode, By Therapeutic Application
    • Market Nasal Drug Delivery Mode, By Dosage Form
    • Market Nasal Drug Delivery Mode, By Container Type
    • Market Nasal Drug Delivery Mode, By System Type
    • Market Nasal Drug Delivery Mode, By End Users
    • Market Nasal Drug Delivery Mode, By Distribution
    • Market Nasal Drug Delivery Mode, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in adoption of self-administration practices
    • Stringent rules and regulations
    • Outbreak of COVID-19 (pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Nasal Drug Delivery Mode Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Nasal Drug Delivery Mode Market, By Therapeutic Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Asthma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Rhinitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Nasal Drug Delivery Mode Market, By Dosage Form, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Gel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Nasal Drug Delivery Mode Market, By Container Type, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Pressurized Container
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Non-Pressurized Container
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Nasal Drug Delivery Mode Market, By System Type, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Multi-Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Bi-Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Unit Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

9. Nasal Drug Delivery Mode Market, By End User, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Homecare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

10. Nasal Drug Delivery Mode Market, By Distribution, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

11. Nasal Drug Delivery Mode Market, By Region, 2021 to 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

12. Competitive Landscape

  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline Plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astra Zeneca
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Services Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mystic Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bausch Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PendoPharm Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Optinose
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cadila Pharmaceutical s Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 3M
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reddy Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aptar Group Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neurelis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ENT Technologies Pty Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Analyst Views

13. Section

  • Research Methodology
  • About us